REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $11,551,000 | -30.6% | 114,806 | -2.4% | 0.43% | -27.9% |
| Q2 2021 | $16,651,000 | +24.0% | 117,649 | -12.7% | 0.59% | +35.2% |
| Q1 2021 | $13,432,000 | -20.0% | 134,723 | -0.8% | 0.44% | -25.9% |
| Q4 2020 | $16,791,000 | -0.5% | 135,828 | -21.6% | 0.59% | -13.1% |
| Q3 2020 | $16,882,000 | -15.2% | 173,292 | +35.8% | 0.68% | -20.5% |
| Q2 2020 | $19,914,000 | +36.7% | 127,638 | +26.5% | 0.86% | +5.0% |
| Q1 2020 | $14,568,000 | -31.7% | 100,926 | -3.3% | 0.81% | +12.7% |
| Q4 2019 | $21,332,000 | +148.4% | 104,349 | -2.4% | 0.72% | +135.2% |
| Q3 2019 | $8,588,000 | -16.6% | 106,968 | -2.0% | 0.31% | -10.2% |
| Q2 2019 | $10,297,000 | +3.9% | 109,131 | -5.9% | 0.34% | +7.2% |
| Q1 2019 | $9,908,000 | – | 115,918 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |